Δημοσίευση

Determination of prooxidant--antioxidant balance after acute coronary syndrome using a rapid assay: a pilot study.

ΤίτλοςDetermination of prooxidant--antioxidant balance after acute coronary syndrome using a rapid assay: a pilot study.
Publication TypeJournal Article
Year of Publication2009
AuthorsGhayour-Mobarhan, M., Alamdari D. Hamidi, Moohebati M., Sahebkar A., Nematy M., Safarian M., Azimi-Nezhad M., Parizadeh S. Mohammad R., Tavallaie S., Koliakos G., & Ferns G.
JournalAngiology
Volume60
Issue6
Pagination657-62
Date Published2009 Dec-2010 Jan
ISSN1940-1574
Λέξεις κλειδιάAcute Coronary Syndrome, Antioxidants, Biological Markers, Disease Progression, Enzyme-Linked Immunosorbent Assay, Female, Follow-Up Studies, Humans, Male, Middle Aged, Oxidative Stress, Pilot Projects, Prognosis, Reactive Oxygen Species, Retrospective Studies, Risk Factors, Severity of Illness Index
Abstract

The purpose of the current study was to investigate a novel measure of oxidative stress in patients with acute coronary syndrome (ACS) using a pro-oxidant-antioxidant balance (PAB) assay, which is simple and rapid. Blood samples were taken from 94 patients admitted with ACS. Pro-oxidant-antioxidant balance values were determined in the first and second 12 hours after the onset of symptoms and compared with values for 81 age- and sex-matched controls. The mean PAB values in the first and second 12-hour samples of patients were both significantly higher than that of controls (P < .001). Among patients, PAB values were also significantly higher in the second samples compared with the first samples (P < .001). These findings indicate a heightened state of oxidative stress following ACS and suggest that the PAB value may be considered as a cardiovascular risk predictor to estimate the extent of oxidative stress.

DOI10.1177/0003319709333868
Alternate JournalAngiology
PubMed ID19398426

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.